IL91063A - 5,6,7,8-Tetrahydro-H4-thiazolo [B-4,5] collectors, their preparations and preparations containing them to inhibit lipoxygenase and lipopoxide formation - Google Patents

5,6,7,8-Tetrahydro-H4-thiazolo [B-4,5] collectors, their preparations and preparations containing them to inhibit lipoxygenase and lipopoxide formation

Info

Publication number
IL91063A
IL91063A IL9106389A IL9106389A IL91063A IL 91063 A IL91063 A IL 91063A IL 9106389 A IL9106389 A IL 9106389A IL 9106389 A IL9106389 A IL 9106389A IL 91063 A IL91063 A IL 91063A
Authority
IL
Israel
Prior art keywords
group
compound
substituted
amino
thiazolo
Prior art date
Application number
IL9106389A
Other languages
English (en)
Hebrew (he)
Other versions
IL91063A0 (en
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of IL91063A0 publication Critical patent/IL91063A0/xx
Publication of IL91063A publication Critical patent/IL91063A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL9106389A 1988-07-22 1989-07-21 5,6,7,8-Tetrahydro-H4-thiazolo [B-4,5] collectors, their preparations and preparations containing them to inhibit lipoxygenase and lipopoxide formation IL91063A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18422088 1988-07-22
JP8653689 1989-04-05

Publications (2)

Publication Number Publication Date
IL91063A0 IL91063A0 (en) 1990-02-09
IL91063A true IL91063A (en) 1994-12-29

Family

ID=26427638

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9106389A IL91063A (en) 1988-07-22 1989-07-21 5,6,7,8-Tetrahydro-H4-thiazolo [B-4,5] collectors, their preparations and preparations containing them to inhibit lipoxygenase and lipopoxide formation

Country Status (11)

Country Link
US (3) US4956360A (ja)
EP (1) EP0351856B1 (ja)
JP (1) JP3054738B2 (ja)
KR (1) KR970011396B1 (ja)
AT (1) ATE184610T1 (ja)
AU (1) AU610739B2 (ja)
CA (1) CA1336431C (ja)
DE (1) DE68929074T2 (ja)
DK (1) DK362889A (ja)
IL (1) IL91063A (ja)
NZ (1) NZ230042A (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89351A0 (en) * 1988-03-14 1989-09-10 Lundbeck & Co As H 4,5,6,7-tetrahydroisothiazolo(4,5-c)pyridines,process for their preparation and pharmaceutical compositions containing them
DE3820775A1 (de) * 1988-06-20 1989-12-21 Thomae Gmbh Dr K Neue 4,5,7,8-tetrahydro-6h-thiazolo(5,4,-d)azepine, ihre herstellung und ihre verwendung als arzneimittel
DE4134467A1 (de) * 1991-10-18 1993-04-22 Thomae Gmbh Dr K Heterobiarylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL97249A (en) * 1990-02-23 1995-01-24 Takeda Chemical Industries Ltd Compounds of 7,6,5,4-tetrahydrothiazole] B-5,4 [pyridine and compounds of 5,6-dihydro-H4-pyrrolo] D-3,2 [thiazole, their manufacture, and pharmaceutical compositions including or
GB9219779D0 (en) * 1992-09-18 1992-10-28 Rhone Poulenc Agriculture Compositions of new matter
DE4324580A1 (de) * 1993-07-22 1995-01-26 Thomae Gmbh Dr K Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
AU5857296A (en) * 1995-05-17 1996-11-29 Eli Lilly And Company Use of leukotriene antagonists for alzheimer's disease
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
GB2312621B (en) * 1996-05-02 1998-03-11 Pharma Nord Uk Limited Anti-oxidant medicament
US6433935B2 (en) 1996-07-02 2002-08-13 Three-Five Systems, Inc. Display illumination system
WO2000078761A1 (en) * 1999-06-23 2000-12-28 Sepracor, Inc. Indolyl-benzimidazole antibacterials, and methods of use thereof
US6649318B1 (en) 2000-04-20 2003-11-18 Eastman Kodak Company Self-contained imaging media comprising microencapsulated color formers and a resilient layer
US7148248B2 (en) 2002-11-29 2006-12-12 Masako Nozaki Method of treating or inhibiting the development of brain inflammation and sepsis
EP1424101A3 (en) * 2002-11-29 2004-08-18 NOZAKI, Masako Use of a leukotriene C4 and D4 receptor antagonist for the preparation of a medicament for treating or preventing brain inflammation and sepsis
PT1691814E (pt) * 2003-12-01 2012-10-16 Cambridge Entpr Ltd Agentes anti-inflamatórios
JP5209471B2 (ja) 2005-06-15 2013-06-12 ケンブリッジ・エンタープライズ・リミテッド 抗炎症剤
GB201009603D0 (en) * 2010-06-08 2010-07-21 Cambridge Entpr Ltd Anti-inflammatory agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG17786A3 (ja) * 1970-08-14 1973-12-25
JPS53121781A (en) * 1977-03-30 1978-10-24 Torii Yakuhin Kk Caprolactum derivatives
AU554388B2 (en) * 1981-06-15 1986-08-21 American Home Products Corporation Alpha-phenyl-2-(aza)benzothiazolylthioglycolic acid derivatives
JPS5837097A (ja) * 1981-08-28 1983-03-04 味の素株式会社 界面活性剤
JPS63283591A (ja) * 1986-12-17 1988-11-21 Toray Ind Inc Ｌ−α−アミノ−ε−カプロラクタムの製造法

Also Published As

Publication number Publication date
EP0351856B1 (en) 1999-09-15
US5118806A (en) 1992-06-02
US5300639A (en) 1994-04-05
KR910002873A (ko) 1991-02-26
JP3054738B2 (ja) 2000-06-19
IL91063A0 (en) 1990-02-09
EP0351856A3 (en) 1991-08-07
JPH0347188A (ja) 1991-02-28
DE68929074D1 (de) 1999-10-21
EP0351856A2 (en) 1990-01-24
DK362889D0 (da) 1989-07-21
NZ230042A (en) 1990-10-26
DK362889A (da) 1990-01-23
AU3886289A (en) 1990-01-25
CA1336431C (en) 1995-07-25
DE68929074T2 (de) 2000-01-05
AU610739B2 (en) 1991-05-23
ATE184610T1 (de) 1999-10-15
US4956360A (en) 1990-09-11
KR970011396B1 (ko) 1997-07-10

Similar Documents

Publication Publication Date Title
CA1336431C (en) Thiazolo(5,4-b)azepine compounds
JP5092402B2 (ja) ピラゾロピリジン誘導体
KR100394761B1 (ko) 헤테로바이사이클릭유도체
EP3548468B1 (en) Tricyclic rho kinase inhibitors
CA2763960C (en) Bicyclic and tricyclic compounds as kat ii inhibitors
WO2008027466A1 (en) Hydantoin derivatives useful as antibacterial agents
WO2012006202A1 (en) Rho kinase inhibitors
SK126993A3 (en) Thiopyranopyrrole derivatives, method of their preparation and pharmaceutical compositions containing them
EP0579496A1 (en) 4-Aminoquinazoline derivatives, and their use as medicine
CA2036905C (en) Condensed thiazole compounds, their production and use
EP2491026A1 (en) Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators
WO2016100166A1 (en) SUBSTITUTED DIHYDRO-1H-PYRROLO[3,2-c]PYRIDIN-4(5H)-ONES AS RIPK3 INHIBITORS
JPH03206042A (ja) 降圧剤
US6977262B2 (en) Dihydropyrazolopyridine compounds and pharmaceutical use thereof
JP3111321B2 (ja) 縮合チアゾール化合物
US4703051A (en) 4,7-dihydrothieno[2,3-B]pyridine derivatives useful in the treatment of cardiovascular diseases
US6506773B2 (en) Hydroxamic and carboxylic acid derivatives
EP3915990A1 (en) 4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-3,6-dihydropyridine-1-(2h)-carboxamide derivatives as limk and/or rock kinases inhibitors for use in the treatment of cancer
JP3358069B2 (ja) 三環性複素環類、その製造法及び剤
CN115141204A (zh) 一种萘[1,2-b]呋喃-4,5-二酮衍生物其制备及其用途
FI80459C (fi) Nya 3- eller 5-(3-pyridyl)substituerade 1h,3h-pyrrolo/1,2-c/tiazol-7-karboxylsyror, vilka aer mellanprodukter vid framstaellning av motsvarande terapeutiskt anvaendbara pyrrolotiazol-7-karboxylsyraamider och foerfarande foer framstaellning daerav.
Youssef Reactions of 2-amino-4, 5, 6, 7-tetrahydro [1] benzothiophene-3-carbonitrile and 6-amino-1, 4-dihydro-3-methyl-1, 4-diphenylpyrano [2, 3-c] pyrazole-5-carbonitrile with substituted benzylidenemalononitriles, α, β-acetylenic esters and ketones

Legal Events

Date Code Title Description
RH Patent void